Literature DB >> 2882519

Human peroxisomal 3-oxoacyl-coenzyme A thiolase deficiency.

A W Schram, S Goldfischer, C W van Roermund, E M Brouwer-Kelder, J Collins, T Hashimoto, H S Heymans, H van den Bosch, R B Schutgens, J M Tager.   

Abstract

We investigated the peroxisomal beta-oxidation system in liver from a patient with clinical features similar to those in the cerebrohepatorenal (Zellweger) syndrome and with elevated levels in body fluids of very-long-chain fatty acids and intermediates in the biosynthesis of bile acids. The peroxisomal beta-oxidation of fatty acids, measured as the cyanide-insensitive formation of [14C]acetyl units from [14C]palmitoyl-CoA, was very low in the patient (less than 10% of the values in control subjects). Immunoblotting experiments using antibodies to peroxisomal beta-oxidation enzymes indicated that peroxisomal 3-oxoacyl-CoA thiolase (acyl-CoA:acetyl-CoA C-acyltransferase, EC 2.3.1.16) was deficient. Addition of purified rat-liver peroxisomal 3-oxoacyl-CoA thiolase to a reaction mixture containing liver homogenate from the patient restored peroxisomal beta-oxidation. We conclude that the deficiency of peroxisomal 3-oxoacyl-CoA thiolase is responsible for the very low peroxisomal beta-oxidation activity and for the accumulation of very-long-chain fatty acids and intermediates in the biosynthesis of bile acids. Furthermore, the finding that both very-long-chain fatty acids and abnormal bile acids accumulate in this patient suggests that a single peroxisomal 3-oxoacyl-CoA thiolase is involved in the oxidative chain shortening of both very-long-chain fatty acids and the coprostanoic acids.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 2882519      PMCID: PMC304678          DOI: 10.1073/pnas.84.8.2494

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  18 in total

1.  Peroxisomal and mitochondrial defects in the cerebro-hepato-renal syndrome.

Authors:  S Goldfischer; C L Moore; A B Johnson; A J Spiro; M P Valsamis; H K Wisniewski; R H Ritch; W T Norton; I Rapin; L M Gartner
Journal:  Science       Date:  1973-10-05       Impact factor: 47.728

Review 2.  Review: the cerebrohepatorenal syndrome of Zellweger, morphologic and metabolic aspects.

Authors:  R I Kelley
Journal:  Am J Med Genet       Date:  1983-12

3.  Biosynthesis and intracellular transport of enzymes of peroxisomal beta-oxidation.

Authors:  S Miura; M Mori; M Takiguchi; M Tatibana; S Furuta; S Miyazawa; T Hashimoto
Journal:  J Biol Chem       Date:  1984-05-25       Impact factor: 5.157

4.  Degradation of cholesterol to propionic acid by rat liver peroxisomes.

Authors:  L R Hagey; S K Krisans
Journal:  Biochem Biophys Res Commun       Date:  1982-08       Impact factor: 3.575

5.  Peroxisomal beta oxidation system of rat liver. Copurification of enoyl-CoA hydratase and 3-hydroxyacyl-CoA dehydrogenase.

Authors:  T Osumi; T Hashimoto
Journal:  Biochem Biophys Res Commun       Date:  1979-07-27       Impact factor: 3.575

6.  Deficiency of acyl-CoA: dihydroxyacetone phosphate acyltransferase in patients with Zellweger (cerebro-hepato-renal) syndrome.

Authors:  R B Schutgens; G J Romeyn; R J Wanders; H van den Bosch; G Schrakamp; H S Heymans
Journal:  Biochem Biophys Res Commun       Date:  1984-04-16       Impact factor: 3.575

7.  Purification and properties of acyl-CoA oxidase from rat liver.

Authors:  T Osumi; T Hashimoto; N Ui
Journal:  J Biochem       Date:  1980-06       Impact factor: 3.387

8.  Formation of cholic acid from 3 alpha, 7 alpha, 12 alpha-trihydroxy-5 beta-cholestanoic acid by rat liver peroxisomes.

Authors:  F Kase; I Björkhem; J I Pedersen
Journal:  J Lipid Res       Date:  1983-12       Impact factor: 5.922

9.  Lignoceric acid is oxidized in the peroxisome: implications for the Zellweger cerebro-hepato-renal syndrome and adrenoleukodystrophy.

Authors:  I Singh; A E Moser; S Goldfischer; H W Moser
Journal:  Proc Natl Acad Sci U S A       Date:  1984-07       Impact factor: 11.205

10.  Deficiency of enzymes catalyzing the biosynthesis of glycerol-ether lipids in Zellweger syndrome. A new category of metabolic disease involving the absence of peroxisomes.

Authors:  N S Datta; G N Wilson; A K Hajra
Journal:  N Engl J Med       Date:  1984-10-25       Impact factor: 91.245

View more
  54 in total

1.  Functional studies on human Pex7p: subcellular localization and interaction with proteins containing a peroxisome-targeting signal type 2 and other peroxins.

Authors:  Karen Ghys; Marc Fransen; Guy P Mannaerts; Paul P Van Veldhoven
Journal:  Biochem J       Date:  2002-07-01       Impact factor: 3.857

Review 2.  Rhizomelic chondrodysplasia punctata, a peroxisomal biogenesis disorder caused by defects in Pex7p, a peroxisomal protein import receptor: a minireview.

Authors:  P E Purdue; M Skoneczny; X Yang; J W Zhang; P B Lazarow
Journal:  Neurochem Res       Date:  1999-04       Impact factor: 3.996

Review 3.  Peroxisomal disorders: clinical, biochemical, and molecular aspects.

Authors:  R J Wanders
Journal:  Neurochem Res       Date:  1999-04       Impact factor: 3.996

4.  Zellweger-like phenotype in two siblings: a defect in peroxisomal beta-oxidation with elevated very long-chain fatty acids but normal bile acids.

Authors:  H Mandel; M Berant; A Aizin; R Gershony; S Hemmli; R B Schutgens; R J Wanders
Journal:  J Inherit Metab Dis       Date:  1992       Impact factor: 4.982

5.  Di- and trihydroxycholestanoic acidaemia with hepatic failure.

Authors:  H Przyrembel; R J Wanders; C W van Roermund; R B Schutgens; G P Mannaerts; M Casteels
Journal:  J Inherit Metab Dis       Date:  1990       Impact factor: 4.982

6.  A new peroxisomal beta-oxidation disorder in twin neonates: defective oxidation of both cerotic and pristanic acids.

Authors:  E Christensen; S A Pedersen; H Leth; C Jakobs; R B Schutgens; R J Wanders
Journal:  J Inherit Metab Dis       Date:  1997-09       Impact factor: 4.982

Review 7.  Zellweger syndrome and associated phenotypes.

Authors:  D R FitzPatrick
Journal:  J Med Genet       Date:  1996-10       Impact factor: 6.318

Review 8.  Peroxisomal disorders: a review.

Authors:  B Fournier; J A Smeitink; L Dorland; R Berger; J M Saudubray; B T Poll-The
Journal:  J Inherit Metab Dis       Date:  1994       Impact factor: 4.982

Review 9.  Metabolic disorders of embryogenesis.

Authors:  G K Brown
Journal:  J Inherit Metab Dis       Date:  1994       Impact factor: 4.982

10.  Isolated defect of peroxisomal beta-oxidation in a 16-year-old patient.

Authors:  R Santer; A Claviez; H D Oldigs; J Schaub; R B Schutgens; R J Wanders
Journal:  Eur J Pediatr       Date:  1993-04       Impact factor: 3.183

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.